1 articles with this tag
Irish MedTech startup ProVerum secured €68.6 million in Series B equity financing. MVM Partners led the round, joined by new investors OrbiMed and ISIF, alongside existing backers. This capital injection will advance the commercialization of ProVerum's minimally invasive solution for benign prostatic hyperplasia.
